Remembering Professor José Baselga

por Tabernero, J.
Publicado 2021

Corrigendum to ‘Remembering Professor José Baselga’: [ESMO Open Volume 6, Issue 3, June 2021, 100121]

por Tabernero, J.
Publicado 2021

ESMO pays tribute to Professor José Baselga

por Peters, S., Tabernero, J., Cervantes, A., Banerjee, S., Giuliani, R., Lordick, F.
Publicado 2021

ESMO pays tribute to Professor José Baselga

por Peters, S., Tabernero, J., Cervantes, A., Banerjee, S., Giuliani, R., Lordick, F.
Publicado 2021

Different hCG assays to measure ectopic hCG secretion in bladder carcinoma patients.

por Mora, J., Gascón, N., Tabernero, J. M., Rodríguez-Espinosa, J., González-Sastre, F.
Publicado 1996

Mean overall survival gain with aflibercept plus FOLFIRI vs placebo plus FOLFIRI in patients with previously treated metastatic colorectal cancer

por Joulain, F, Proskorovsky, I, Allegra, C, Tabernero, J, Hoyle, M, Iqbal, S U, Van Cutsem, E
Publicado 2013

Microsatellite instability due to hMLH1 deficiency is associated with increased cytotoxicity to irinotecan in human colorectal cancer cell lines

por Vilar, E, Scaltriti, M, Balmaña, J, Saura, C, Guzman, M, Arribas, J, Baselga, J, Tabernero, J
Publicado 2008

Advances in the systemic treatment of therapeutic approaches in biliary tract cancer

por Mirallas, O., López-Valbuena, D., García-Illescas, D., Fabregat-Franco, C., Verdaguer, H., Tabernero, J., Macarulla, T.
Publicado 2022

Sex and gender perspectives in colorectal cancer

por Baraibar, I., Ros, J., Saoudi, N., Salvà, F., García, A., Castells, M.R., Tabernero, J., Élez, E.
Publicado 2023

Phase II study of necitumumab plus modified FOLFOX6 as first-line treatment in patients with locally advanced or metastatic colorectal cancer

por Elez, E, Hendlisz, A, Delaunoit, T, Sastre, J, Cervantes, A, Varea, R, Chao, G, Wallin, J, Tabernero, J
Publicado 2016

Incorporating BEAMing technology as a liquid biopsy into clinical practice for the management of colorectal cancer patients: an expert taskforce review

por García-Foncillas, J, Alba, E, Aranda, E, Díaz-Rubio, E, López-López, R, Tabernero, J, Vivancos, A
Publicado 2017

Phase II multicohort study of atezolizumab monotherapy in multiple advanced solid cancers

por Tabernero, J., Andre, F., Blay, J.-Y., Bustillos, A., Fear, S., Ganta, S., Jaeger, D., Maio, M., Mileshkin, L., Melero, I.
Publicado 2022

Primary tumor sidedness has an impact on prognosis and treatment outcome in metastatic colorectal cancer: results from two randomized first-line panitumumab studies

por Boeckx, N., Koukakis, R., Op de Beeck, K., Rolfo, C., Van Camp, G., Siena, S., Tabernero, J., Douillard, J.-Y., André, T., Peeters, M.
Publicado 2017

Phase I study of FOLFIRI plus pimasertib as second-line treatment for KRAS-mutated metastatic colorectal cancer

por Macarulla, T, Cervantes, A, Tabernero, J, Roselló, S, Van Cutsem, E, Tejpar, S, Prenen, H, Martinelli, E, Troiani, T, Laffranchi, B, Jego, V, von Richter, O, Ciardiello, F
Publicado 2015

Beyond the lessons learned from the COVID-19 pandemic: opportunities to optimize clinical trial implementation in oncology

por Castelo-Branco, L., Awada, A., Pentheroudakis, G., Perez-Gracia, J.L., Mateo, J., Curigliano, G., Banerjee, S., Giuliani, R., Lordick, F., Cervantes, A., Tabernero, J., Peters, S.
Publicado 2021

Antitumor activity of lurbinectedin in combination with oral capecitabine in patients with metastatic breast cancer

por Awada, A.H., Boni, V., Moreno, V., Aftimos, P., Kahatt, C., Luepke-Estefan, X.E., Siguero, M., Fernandez-Teruel, C., Cullell-Young, M., Tabernero, J.
Publicado 2022

Efficacy of trifluridine and tipiracil (TAS-102) versus placebo, with supportive care, in a randomized, controlled trial of patients with metastatic colorectal cancer from Spain: r...

por Longo-Muñoz, F., Argiles, G., Tabernero, J., Cervantes, A., Gravalos, C., Pericay, C., Gil-Calle, S., Mizuguchi, H., Carrato-Mena, A., Limón, M. L., Garcia-Carbonero , R.
Publicado 2016

The impact of COVID-19 on cancer care and oncology clinical research: an experts’ perspective

por Sessa, C., Cortes, J., Conte, P., Cardoso, F., Choueiri, T., Dummer, R., Lorusso, P., Ottmann, O., Ryll, B., Mok, T., Tempero, M., Comis, S., Oliva, C., Peters, S., Tabernero, J.
Publicado 2021

MODUL cohort 2: an adaptable, randomized, signal-seeking trial of fluoropyrimidine plus bevacizumab with or without atezolizumab maintenance therapy for BRAF(wt) metastatic colorec...

por Tabernero, J., Grothey, A., Arnold, D., de Gramont, A., Ducreux, M., O’Dwyer, P., Tahiri, A., Gilberg, F., Irahara, N., Schmoll, H.-J., Van Cutsem, E.
Publicado 2022

Fusobacterium nucleatum persistence and risk of recurrence after preoperative treatment in locally advanced rectal cancer

por Serna, G., Ruiz-Pace, F., Hernando, J., Alonso, L., Fasani, R., Landolfi, S., Comas, R., Jimenez, J., Elez, E., Bullman, S., Tabernero, J., Capdevila, J., Dienstmann, R., Nuciforo, P.
Publicado 2020